Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Peres

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
International Journal of Epidemiology|December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|March 28, 2018
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaDoris K Hansen, Lauren C Peres, Danai Dima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaDoris K Hansen, Lauren C Peres, Danai Dima, et al.
Blood Advances|March 15, 2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myelomaRahul Banerjee, Alicia Richards, Shonali Midha, et al.
British Journal of Cancer|June 29, 2026
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
International Journal of Epidemiology|December 7, 2017
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
International Journal of Epidemiology|March 28, 2018
Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studiesLauren C Peres, Harvey Risch, Kathryn L Terry, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2025
Erratum: Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaDoris K Hansen, Lauren C Peres, Danai Dima, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2025
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple MyelomaDoris K Hansen, Lauren C Peres, Danai Dima, et al.
Blood Advances|March 15, 2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myelomaRahul Banerjee, Alicia Richards, Shonali Midha, et al.
British Journal of Cancer|June 29, 2026
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Medicine|April 20, 2019
Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American WomenDelores J Grant, Ani Manichaikul, Anthony J Alberg, et al.
Pageof 21